The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The JAX patient-derived xenograft program: A unique resource to advance genome-guided cancer medicine and therapeutic agent testing.
Carol J. Bult
No relevant relationships to disclose
Susan D. Airhart
No relevant relationships to disclose
Jeffrey Chuang
No relevant relationships to disclose
Regina Gandour-Edwards
No relevant relationships to disclose
Joshy George
No relevant relationships to disclose
Joel Graber
No relevant relationships to disclose
R. Krishna Murthy Karuturi
No relevant relationships to disclose
James Keck
No relevant relationships to disclose
Hyunsoo Kim
No relevant relationships to disclose
Primo Lara
No relevant relationships to disclose
Tianhong Li
No relevant relationships to disclose
Philip C. Mack
No relevant relationships to disclose
Lenny Shultz
No relevant relationships to disclose
Clifford Tepper
No relevant relationships to disclose
Rebekah Burich
No relevant relationships to disclose
Xing Yi Woo
No relevant relationships to disclose
Yan Yang
No relevant relationships to disclose
Ralph de Vere White
No relevant relationships to disclose
David R. Gandara
No relevant relationships to disclose
Edison T. Liu
No relevant relationships to disclose